Stockreport

Design Therapeutics to Participate in Multiple Upcoming Investor Conferences

Design Therapeutics, Inc.  (DSGN) 
PDF CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious [Read more]